Tibet Rhodiola Pharmaceutical Holding Co. 600211.SS Stock
44.66 CNY
{{ price }}
2.126687%
{{change_pct}}%
SECTOR
Healthcare
COUNTRY
China
Exchange
Shanghai
Market Cap
11.07B CNY
LOW - HIGH [24H]
43.57
-
44.94 CNY
VOLUME [24H]
1.67M CNY
{{ volume }}
P/E Ratio
13.82
Earnings per share
3.23 CNY
Tibet Rhodiola Pharmaceutical Holding Co. Price Chart
Tibet Rhodiola Pharmaceutical Holding Co. 600211.SS Financial and Trading Overview
Contents
- Tibet Rhodiola Pharmaceutical Holding Co. Price Chart
- Tibet Rhodiola Pharmaceutical Holding Co. 600211.SS Financial and Trading Overview
- Valuation Measures
- Trading Information
- Financial Highlights
- Profile of Tibet Rhodiola Pharmaceutical Holding Co.
- Q&A For Tibet Rhodiola Pharmaceutical Holding Co. Stock
| Tibet Rhodiola Pharmaceutical Holding Co. stock price | 44.66 CNY |
| Previous Close | 54.88 CNY |
| Open | 54.89 CNY |
| Bid | 54.66 CNY x 0 |
| Ask | 54.68 CNY x 0 |
| Day's Range | 54.35 - 55.84 CNY |
| 52 Week Range | 31.2 - 66.5 CNY |
| Volume | 2.64M CNY |
| Avg. Volume | 4.98M CNY |
| Market Cap | 13.55B CNY |
| Beta (5Y Monthly) | 0.882876 |
| PE Ratio (TTM) | 27.19403 |
| EPS (TTM) | 3.23 CNY |
| Forward Dividend & Yield | 0.75 (1.35%) |
| Ex-Dividend Date | April 17, 2023 |
| 1y Target Est | N/A |
600211.SS Valuation Measures
| Enterprise Value | 11.83B CNY |
| Trailing P/E | 27.19403 |
| Forward P/E | 15.310925 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 4.83077 |
| Price/Book (mrq) | 4.053092 |
| Enterprise Value/Revenue | 4.217 |
| Enterprise Value/EBITDA | 13.763 |
Trading Information
Tibet Rhodiola Pharmaceutical Holding Co. Stock Price History
| Beta (5Y Monthly) | 0.882876 |
| 52-Week Change | 39.64% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 66.5 CNY |
| 52 Week Low | 31.2 CNY |
| 50-Day Moving Average | 57.55 CNY |
| 200-Day Moving Average | 44.99 CNY |
600211.SS Share Statistics
| Avg. Volume (3 month) | 4.98M CNY |
| Avg. Daily Volume (10-Days) | 2.84M CNY |
| Shares Outstanding | 247.94M |
| Float | 92.52M |
| Short Ratio | N/A |
| % Held by Insiders | 62.10% |
| % Held by Institutions | 1.51% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0.746 |
| Trailing Annual Dividend Yield | 1.35% |
| 5 Year Average Dividend Yield | 121.00% |
| Payout Ratio | 0.1682 |
| Last Split Factor | 1.4:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 17.76% |
| Operating Margin (ttm) | 28.27% |
| Gross Margin | 92.55% |
| EBITDA Margin | 30.63% |
Management Effectiveness
| Return on Assets (ttm) | 11.40% |
| Return on Equity (ttm) | 16.79% |
Income Statement
| Revenue (ttm) | 2.81B CNY |
| Revenue Per Share (ttm) | 11.32 CNY |
| Quarterly Revenue Growth (yoy) | 38.20% |
| Gross Profit (ttm) | 2.35B CNY |
| EBITDA | 859.49M CNY |
| Net Income Avi to Common (ttm) | 498.34M CNY |
| Diluted EPS (ttm) | 2.01 |
| Quarterly Earnings Growth (yoy) | 73.59% |
Balance Sheet
| Total Cash (mrq) | 2.42B CNY |
| Total Cash Per Share (mrq) | 9.76 CNY |
| Total Debt (mrq) | 542.18M CNY |
| Total Debt/Equity (mrq) | 16.11 CNY |
| Current Ratio (mrq) | 2.636 |
| Book Value Per Share (mrq) | 13.486 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 978.7M CNY |
| Levered Free Cash Flow (ttm) | 609.86M CNY |
Profile of Tibet Rhodiola Pharmaceutical Holding Co.
| Country | China |
| State | N/A |
| City | Lhasa |
| Address | Lhasa Economic and Tech Dev Zn |
| ZIP | 850000 |
| Phone | 86 89 1683 6521 |
| Website | https://www.xzyy.cn |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 615 |
Tibet Rhodiola Pharmaceutical Holding Co. engages in the research and development, production, and sale of pharmaceuticals in China and internationally. It offers biological products, Tibetan medicine, Chinese medicine, and chemical medicine products. The company was founded in 1999 and is based in Lhasa, China.
Q&A For Tibet Rhodiola Pharmaceutical Holding Co. Stock
What is a current 600211.SS stock price?
Tibet Rhodiola Pharmaceutical Holding Co. 600211.SS stock price today per share is 44.66 CNY.
How to purchase Tibet Rhodiola Pharmaceutical Holding Co. stock?
You can buy 600211.SS shares on the Shanghai exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Tibet Rhodiola Pharmaceutical Holding Co.?
The stock symbol or ticker of Tibet Rhodiola Pharmaceutical Holding Co. is 600211.SS.
Which industry does the Tibet Rhodiola Pharmaceutical Holding Co. company belong to?
The Tibet Rhodiola Pharmaceutical Holding Co. industry is Drug Manufacturers-Specialty & Generic.
How many shares does Tibet Rhodiola Pharmaceutical Holding Co. have in circulation?
The max supply of Tibet Rhodiola Pharmaceutical Holding Co. shares is 247.94M.
What is Tibet Rhodiola Pharmaceutical Holding Co. Price to Earnings Ratio (PE Ratio)?
Tibet Rhodiola Pharmaceutical Holding Co. PE Ratio is 13.82662500 now.
What was Tibet Rhodiola Pharmaceutical Holding Co. earnings per share over the trailing 12 months (TTM)?
Tibet Rhodiola Pharmaceutical Holding Co. EPS is 3.23 CNY over the trailing 12 months.
Which sector does the Tibet Rhodiola Pharmaceutical Holding Co. company belong to?
The Tibet Rhodiola Pharmaceutical Holding Co. sector is Healthcare.